Forecasting The Future: 13 Analyst Projections For Viridian Therapeutics
Forecasting The Future: 13 Analyst Projections For Viridian Therapeutics
預測未來：Viridian Therapeutics 的 13 位分析師預測
The standing of Viridian Therapeutics...Analysts' ratings for Viridian Therapeutics (NASDAQ:VRDN) over the last quarter vary from bullish to bearish, as provided by 13 analysts.
過去一個季度，13位分析師對Viridian Therapeutics（納斯達克股票代碼：VRDN）的評級從看好到看淡不一。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天內情緒的變化，並將它們與前幾個月進行比較。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.69, a high estimate of $61.00, and a low estimate of $27.00. Witnessing a positive shift, the current average has risen by 7.69% from the previous average price target of $35.00.
由分析師分析得出的12個月目標價提供了洞察，平均目標價爲37.69美元，最高估值爲61.00美元，最低估值爲27.00美元。目前的平均值呈現積極變化，比以前的平均目標價35.00美元上升了7.69%。
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The standing of Viridian Therapeutics...
通過對最近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。